Search

everythinglearnresearchcommunity

for

Search:↓

The Fatty Liver Index (FLI) may not be enough to rule out non-alcoholic fatty liver disease in lean women with polycystic ovary syndrome.

A mutation in the EDNRA gene causes Oro-Oto-Cardiac syndrome, affecting face and heart development.

The PCOS questionnaire is valid for Indian women, but metformin doesn't significantly improve symptoms beyond oral contraceptives.

Females with idiopathic hirsutism have higher levels of omentin-1, which may lead to excessive hair growth.

Negative illness perceptions increase emotional distress, worsening OCD symptoms in alopecia areata patients.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Acne patients have higher levels of oxidative stress, but it's not clear if it causes or results from acne; antioxidants might help treat acne.

Low quality of life and high HSS-29 scores increase risk of losing patients during treatment.

Higher Alarin levels may predict androgenetic alopecia and metabolic syndrome.

Women with PCOS in Nigeria have higher heart risk markers, needing early heart health checks.

Finasteride use is linked to a lower risk of bladder cancer, especially in Caucasians and Hispanics.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

Serum AMH levels are a strong marker for diagnosing PCOS in Indian women.

Ornithine decarboxylase is crucial for hair growth and follicle development.

Diagonal earlobe and preauricular creases may indicate higher coronary artery disease risk in men.

The Bethesda system is effective for identifying thyroid cancer but has low sensitivity.

Fetuin-A levels are higher in PCOS patients, suggesting it may play a role in the condition.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Osaterone acetate reduces prostate size and enzyme levels in dogs with benign prostatic hyperplasia.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Fetuin A levels are higher in PCOS patients, while asprosin levels show no difference.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Most adverse reactions to the treatment were mild, with nausea being the most common.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Early detection of ovarian steroid cell tumors is crucial to prevent lasting symptoms.

A specific ATR gene mutation is linked to a hereditary oropharyngeal cancer syndrome.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

The Turkish version of the MAIA-2 Scale is valid and reliable for patients at a dermatology clinic.

FAI is a reliable marker for identifying and monitoring hyperandrogenism in obese adolescent females with PCOS.

Platelet-rich plasma therapy improves oral lichen planus symptoms with few side effects.